Congress funds HPV cancer prevention push, targeting vaccine gaps in underserved communities
H.R. 6561 — PREVENT HPV Cancers Act of 2025 · Filed by Kathy Castor (D-FL) · 8 cosponsors · Introduced Dec 10, 2025 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill directs the CDC to run a national public awareness campaign about HPV vaccination and cancer prevention, funded at $5 million per year through 2030. It also increases funding for the Breast and Cervical Cancer Early Detection Program to $300 million annually through 2030. The campaign will target undervaccinated communities, combat vaccine misinformation, and work with health providers, schools, nonprofits, and state/local health departments to boost HPV vaccination rates and early cancer screening.
Why we flagged it
The bill's operative mechanism is a federally funded public awareness campaign and screening program expansion, both directed at cancer prevention and health equity. It is a straightforward public health appropriation with no private carve-outs or immunity provisions.
What the text implies
- Campaign grants to nonprofit entities may create indirect benefit to vaccine manufacturers through increased demand, though the bill does not name or favor any specific company.
- Expansion of the Breast and Cervical Cancer Early Detection Program may increase screening volume, potentially benefiting diagnostic and treatment providers, but the primary intent is public health access.
The full analysis lists 3 implications of this text.
Who stands to gain
nonprofit organizations (campaign contractors); vaccine manufacturers (indirect demand increase); diagnostic and treatment providers (screening expansion)